A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways ...

Interim results from the global MATTERHORN study mark the first time an immunotherapy has demonstrated statistically ...

Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...

T cells require at least two signals to become activated: one is the complex of a peptide and an MHC molecule, and the other is a costimulatory signal mediated by, for example, the CD80 and CD86 ...

Key secondary endpoints are OS and safety. Imfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80 proteins, ...

A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways ...

Binding of canine CD28 Ig to canine CD80- or CD86-expressing cells was detected using flow cytometry in the presence of various concentrations of canine CTLA-4 Ig. The addition of CTLA-4 Ig reduced ...

Center for Radiopharmaceutical Sciences ETH, PSI and USZ, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland Department of Nuclear Medicine, University Hospital ...